About Emirates Oncology Conference (EOC)
Emirates Oncology Conference is one of the largest health-related conferences in the region with delegates attending from around the Middle East and GCC region.
The conference not only brings together international and local expertise in cancer care and management but also offers to the companies the opportunity to showcase their products and services to the largest gathering of healthcare professionals from the region.
Dear All,
On behalf of the Scientific and Organizing Committee, it gives me great pleasure to extend a very warm welcome to you all on attending the “10th Emirates Oncology Conference”, hosted by Tawam Hospital and SEHA. This year’s conference is set to bring together the latest oncology research and knowledge during a comprehensive three-day programme.
During The Emirates Oncology Conference’s nine years of history, it has long established itself as one of premier medical conferences in the region, and is increasingly being recognized as one of the leading oncology conferences in the global healthcare calendar.
Over 100 world leaders have participated in the conference and engaged in discussions on new approaches in the fight against cancer – discussions that have helped to bring us closer to a future where cancer is a curable disease.
The number of distinguished speakers taking part this year further reinforces the ongoing importance of the conference and, more importantly, is further evidence of the need for continued cooperation on a regional and international scale.
The conference will provide the ideal forum to discuss the latest findings and to improve the outcomes for patients with cancer, which is still one of the biggest challenges of the 22nd century.
A world-class line-up of renowned speakers, leaders and experts in the various fields of cancer diagnosis, treatment and research will highlight the significant advances that have been made in science and clinical practice.
This event will be an important meeting point to inspire and connect leaders, decision makers, doctors, scientists, technologists, public servants and academics to enhance awareness, quality and safety practices to improve the lives of patients with cancer around the world.
We are grateful to all members of the scientific and medical community, our organizing team, speakers, delegates and sponsors for their time, efforts and contributions to making 10th Emirates Oncology Conference one of the most important scientific events of the year.
I wish you all a productive and successful conference and look forward to seeing the results of your debates, discussions and knowledge sharing put into practice.
Dr. Khalid Saeed Balaraj
Chair of Oncology Centre
Tawam Hospital, UAE
Our Committee Members

Mr. Yousef Altheeb Al Ketbi
Acting Group Chief Operations Officer
Corporate Operations
United Arab Emirates

Mr. Khalifa Nasser Al Shamsi
Chief Financial Officer
Al Ain Region
United Arab Emirates

Dr. Khalid Balaraj
Chair of Oncology Service
Tawam Hospital
United Arab Emirates

Dr. Hamda Salem Al Neyadi
Acting Group Marketing and Communications Director
Corporate Marketing & Communication (Dept)
United Arab Emirates

Dr. Jawaher Ansari
Acting Chief of Oncology Clinic
Tawam Hospital
United Arab Emirates

Mr. Mohammad Saleh
Operation Oncology Manager
Tawam Hospital
United Arab Emirates
Meet Our 2022 Speakers

Prof. Abdul Rahman Jazieh
Director of Innovations and Research and Director of International Program
Cincinnati Cancer Advisors
USA

Prof. Abdul Rahman Jazieh
Director of Innovations and Research and Director of International Program , Cincinnati Cancer Advisors | USA
"Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA. Editor in Chief, Global Journal on Quality and Safety in Healthcare. Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA). Specialized in hematology, and oncology with master’s Degree in public health in health education and communication. He published more than 100 articles, books, and book chapters. Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018. "
Sessions by this speaker
Saturday, 2022-11-26
Session 7: Lung Cancer Session
15:40 - 17:30
Lectures by this speaker
Saturday, 2022-11-26
Controversies in Stage III NSCLC Management
14:20 - 14:40
Saturday, 2022-11-26
Panel Discussion and Q&A’s
15:00 - 15:10
Saturday, 2022-11-26
Voting + Panel discussion
17:00 - 17:10
Sunday, 2022-11-27
Case Presentation Lung Cancer
14:00 - 14:45

Dr. Abdul Rahman Al Kinge
Medical Oncologist
Fakeeh University Hospital
United Arab Emirates

Dr. Abdul Rahman Al Kinge
Medical Oncologist , Fakeeh University Hospital | United Arab Emirates
Dr. Abdul Rahman Agha El Kinge has an extensive experience in Medical Oncology. He has trained in Breast Cancer at the MD Anderson Cancer Center, USA, and he is also certified by the European Society of Medical Oncology. Dr. El Kinge is on the editorial board and a reviewer in multiple international medical journals. He is a Fellow of the American College of Physicians, and a member of local and international hematology and oncology societies. He has a keen interest in academics and as a result has multiple peer-reviewed publications. He has initiated and headed multiple oncology and hematology departments in KSA and UAE. He is the Chairperson of the yearly International Oncology and Supportive Care Congress. He has special interest and experience in Precision Medicine and Artificial intelligence in Cancer care.
Sessions by this speaker
Sunday, 2022-11-27
Session 3: Gastrointestinal Session
11:00 - 14:00
Lectures by this speaker
Sunday, 2022-11-27
Panel Discussion and Q & A
12:40 - 13:00

Dr. Abdulla Alhasso
Consultant Clinical Oncologist
The Beatson West of Scotland Cancer Centre
United Arab Emirates

Dr. Abdulla Alhasso
Consultant Clinical Oncologist , The Beatson West of Scotland Cancer Centre | United Arab Emirates
Dr Abdulla Alhasso has joined the Beatson Oncology Centre as a Clinical Oncologist with a special interest in Breast cancer and Urological malignancies. He is actively involved in the provision of clinical services in Clyde area as well as South Glasgow. This involves direct clinical care through outpatient clinics including follow up, new patients and chemotherapy clinics. He is also involved in the medical training and supervision for the junior Oncology team and take an active role in medical research and clinical trials.
Lectures by this speaker
Saturday, 2022-11-26
Breast Hypofractionation
09:30 - 09:50
Saturday, 2022-11-26
Panel Discussion and Q&A’s
10:10 - 10:30

Dr. Abdulla Al Sharm
Director of Comprehensive Cancer Center
King Fahad Medical City
Saudi Arabia

Dr. Abdulla Al Sharm
Director of Comprehensive Cancer Center , King Fahad Medical City | Saudi Arabia
Dr. Abdullah Alsharm is the Director of comprehensive cancer center in King Fahad medical City, Assistant professor in King Saud bin Abdulaziz University for health science and Princess Norah University. Consultant medical oncology at comprehensive cancer center King Fahad Medical City, head of Scientific Committees in Saudi cancer institute and leader of cancer care in ministry of health , graduate from Queens University, Ontario, Canada in 2010, and medical oncology fellowship in gastrointestinal and genitourinary oncology from Queens University in 2011
Lectures by this speaker
Sunday, 2022-11-27
Panel Discussion
12:50 - 13:10
Sunday, 2022-11-27
Bladder Cancer Case Based Discussion
15:40 - 16:25

Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiotherapy
Tawam Hospital
United Arab Emirates

Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiotherapy , Tawam Hospital | United Arab Emirates
Chief of Radiotherapy - Tawam Hospital
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Saturday, 2022-11-26
Session 6: Radiation oncology session
14:00 - 15:40
Lectures by this speaker
Saturday, 2022-11-26
Panel Discussion
15:20 - 15:30

Dr. Adnan Hussain
Consultant Medical Oncologist
King Faisal Specialist Hospital and Research Center
Saudi Arabia

Dr. Adnan Hussain
Consultant Medical Oncologist , King Faisal Specialist Hospital and Research Center | Saudi Arabia
Dr Adnan Hussain works as a Consultant Medical Oncologist at King Faisal Specialist Hospital and Research Center, Jeddah. He has special interest in GI and GU malignancies He did his M.B.B.S from Dow Medical University, Karachi in 2001 after which he moved to UK in 2003 for further training. He did his core medical training and then specialist training in United Kingdom at Belfast Health and Social Care trust followed by which he joined Worcestershire Royal Hospital as a Consultant Medical Oncologist. He moved to KSA in 2015 and currently works at King Faisal Specialist Hospital and Research Center, Jeddah.
Lectures by this speaker
Sunday, 2022-11-27
Bladder Cancer Case Based Discussion
15:40 - 16:25

Dr. Aftab Ahmed Bhatti
Consultant Physician, Urology Clinic
Tawam Hospital
United Arab Emirates

Dr. Aftab Ahmed Bhatti
Consultant Physician, Urology Clinic , Tawam Hospital | United Arab Emirates
Dr Aftab Ahmad Bhatti has recently joined Tawam Hospital as a Consultant Urological Surgeon, after working in the United Kingdom for more than 25 years. The main focus of his work is Urological Oncology, Minimally Invasive Robotic Surgery and Laparoscopic surgery. Dr Aftab A Bhatti graduated from the University of Punjab, Rawalpindi Medical College, Pakistan. He completed his higher urological training from the Northern Deanery, Newcastle upon Tyne, UK. Dr Aftab Bhatti has published over 40 peer reviewed publications and his area of research interest includes kidney and prostate cancer. the area of his interest includes active surveillance for the low risk prostate cancer, surgical anatomy of prostate, refinements to surgical techniques for robotic assisted radical prostatectomy and surgical outcomes of the high risk prostate cancer and prognostic markers for the kidney cancer.
Sessions by this speaker
Friday, 2022-11-25
Sub Scientific Committee
00:00 - 23:55
Sunday, 2022-11-27
Session 2: Genitourinary malignancies- I
08:30 - 11:00
Sunday, 2022-11-27
Session 4: Genitourinary malignancies II - Kidney & Bladder Cancers
11:00 - 14:00
Lectures by this speaker
Sunday, 2022-11-27
Variations in Surgical Techniques during Robot Assisted Radical Prostatectomy an Individualised Approach
08:30 - 08:50
Sunday, 2022-11-27
Panel Discussion and Q&A’s + Voting
09:50 - 10:00
Sunday, 2022-11-27
Panel Discussion
12:50 - 13:10
Sunday, 2022-11-27
Bladder Cancer Case Based Discussion
15:40 - 16:25

Dr. Aladdin Marraoui
Consultant and Chief of Medical Oncology
Gulf International Cancer Centre
United Arab Emirates

Dr. Aladdin Marraoui
Consultant and Chief of Medical Oncology , Gulf International Cancer Centre | United Arab Emirates
Dr. Maarraoui is Consultant and Chief of Hematology/Oncology at Gulf International Cancer Center in Abu Dhabi and Clinical Professor at Gulf Medical University, UAE. He previously served as Chief of Hematology/Oncology at Mafraq Hospital for 14 years. He graduated from Faculty of Medicine at Aleppo University/Syria. He did his Internal Medicine residency at Christ Hospital and Medical Center in Chicago, and his Hematology/Oncology fellowship at the University of Colorado Health Science Center in Denver, Colorado. He is American Board Certified and recertified in Internal medicine in 1992, 2002 and 2012, in Medical Oncology in 1999,2009 and 2019 and in Hematology in 1999, 2009 and 2019. Dr. Maarraoui authored and co-authored several abstracts and articles on Breast Cancer, Colon Cancer, Thyroid Cancer, lung cancer and Lymphoma focusing on these diseases in UAE.
Sessions by this speaker
Saturday, 2022-11-26
Session 3: Advanced Breast Cancer Session
11:00 - 14:00
Lectures by this speaker
Saturday, 2022-11-26
Panel discussion and Q&A’s for first line HR-positive ABC
11:30 - 11:40

Dr. Aly Abdel Razek
Chairman and Executive Director
Gulf International Cancer Center
United Arab Emirates

Dr. Aly Abdel Razek
Chairman and Executive Director , Gulf International Cancer Center | United Arab Emirates
Dr. Abdel Razek graduated from Cairo University. He completed his residency in 1976 at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals. He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee. Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology. He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.
Sessions by this speaker
Saturday, 2022-11-26
Session 8: Neuro-Oncology
15:40 - 17:30
Lectures by this speaker
Saturday, 2022-11-26
Panel Discussion
17:20 - 17:30

Dr. Amar Lal
Hematologist and Oncologist
Tawam Hospital
United Arab Emirates

Dr. Amar Lal
Hematologist and Oncologist , Tawam Hospital | United Arab Emirates
"Dr. Amar Lal graduated from Dow University in 1993. He underwent medicine residency and followed by oncology fellowship. He qualified triple diploma in medicine, family medicine and oncology from CPSP Pakistan. Then he got triple diplomas from Royal Colleges of Physicians Ireland and Glasgow in medicine and speciality certificates oncology royal college London. He also qualified ESMO Examination Board in oncology. He has been local and international speaker in hematology and oncology and has more than 40 publications. He joined Tawam hospital in 2007 and he continued to be an active part of CME/ Scientific Program Coordinator, Member of Pharmacy & Therapeutics Committee (PTC), Patient safety physician manager, Member of Medication Utilization Committee (MSSC). "
Sessions by this speaker
Saturday, 2022-11-26
Session 2: Haematological Malignancies
08:30 - 11:00
Lectures by this speaker
Saturday, 2022-11-26
Panel Discussion and Q&A’s
10:30 - 10:40
2022 Partners & Sponsors
Special thanks to the support, involvement and active contribution of our Partners and Sponsors.